GLP1R and COVID-19: However, in the consistency analysis in the unmatched population, whereadjustments were performed according to individual covariates, GLP-1 RA use was associatedwith a higher risk of incident severe COVID-19 (RR [95% CI]: 1.10 [1.02–1.18]).